[go: up one dir, main page]

KR102208218B1 - 변형된 카디오리핀으로 코팅된 마그네틱 나노비드 및 그 제조 방법 - Google Patents

변형된 카디오리핀으로 코팅된 마그네틱 나노비드 및 그 제조 방법 Download PDF

Info

Publication number
KR102208218B1
KR102208218B1 KR1020197002506A KR20197002506A KR102208218B1 KR 102208218 B1 KR102208218 B1 KR 102208218B1 KR 1020197002506 A KR1020197002506 A KR 1020197002506A KR 20197002506 A KR20197002506 A KR 20197002506A KR 102208218 B1 KR102208218 B1 KR 102208218B1
Authority
KR
South Korea
Prior art keywords
cardiolipin
magnetic
modified
modified cardiolipin
coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197002506A
Other languages
English (en)
Korean (ko)
Other versions
KR20190022762A (ko
Inventor
쿤후이 후
리앙 주
딩비아오 조우
용탕 천
푸전 시아
춘건 치엔
Original Assignee
선전 와이에이치엘오 바이오텍 캄파니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 선전 와이에이치엘오 바이오텍 캄파니 리미티드 filed Critical 선전 와이에이치엘오 바이오텍 캄파니 리미티드
Publication of KR20190022762A publication Critical patent/KR20190022762A/ko
Application granted granted Critical
Publication of KR102208218B1 publication Critical patent/KR102208218B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Magnetic Record Carriers (AREA)
KR1020197002506A 2016-06-30 2016-06-30 변형된 카디오리핀으로 코팅된 마그네틱 나노비드 및 그 제조 방법 Active KR102208218B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/087910 WO2018000339A1 (fr) 2016-06-30 2016-06-30 Nanobille magnétique enduite de cardiolipine modifiée et son procédé de préparation

Publications (2)

Publication Number Publication Date
KR20190022762A KR20190022762A (ko) 2019-03-06
KR102208218B1 true KR102208218B1 (ko) 2021-01-26

Family

ID=60785887

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197002506A Active KR102208218B1 (ko) 2016-06-30 2016-06-30 변형된 카디오리핀으로 코팅된 마그네틱 나노비드 및 그 제조 방법

Country Status (2)

Country Link
KR (1) KR102208218B1 (fr)
WO (1) WO2018000339A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111983221B (zh) * 2020-08-19 2024-04-09 深圳市卓润生物科技有限公司 表面修饰磁珠及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010138A1 (fr) 1989-12-27 1991-07-11 Baxter Diagnostics Inc. Procede d'immobilisation de cardiolipine, de phosphatidylcholine et de cholesterol en phase solide et immunoanalyse
US20040096903A1 (en) * 2001-02-20 2004-05-20 Lang William Kenneth Immobilised cardiolipin probes
JP2009516199A (ja) 2005-11-18 2009-04-16 アメリカ合衆国 修飾カルジオリピンおよびその使用法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4241330A1 (de) * 1992-12-08 1994-06-09 Sabine Dr Lauer Testverfahren zur Differenzierung von gegen Cardiolipin (Anticardiolipin-Antikörper) und gegen einen Komplex aus Cardiolipin und ß2-Glykoprotein I gerichteten Antikörpern
JP3359411B2 (ja) * 1994-03-07 2002-12-24 積水化学工業株式会社 抗リン脂質抗体測定用試薬の製造方法
US7807847B2 (en) * 2004-07-09 2010-10-05 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
EP1894011B1 (fr) * 2005-06-21 2015-09-30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Procedes, immunodosages et dispositifs pour la detection d'anticorps anti-lipoidaux
CN101498715B (zh) * 2009-03-11 2014-03-26 上海尧浩生物技术有限公司 抗心磷脂抗体检测试剂盒及其应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010138A1 (fr) 1989-12-27 1991-07-11 Baxter Diagnostics Inc. Procede d'immobilisation de cardiolipine, de phosphatidylcholine et de cholesterol en phase solide et immunoanalyse
US20040096903A1 (en) * 2001-02-20 2004-05-20 Lang William Kenneth Immobilised cardiolipin probes
JP2009516199A (ja) 2005-11-18 2009-04-16 アメリカ合衆国 修飾カルジオリピンおよびその使用法

Also Published As

Publication number Publication date
WO2018000339A1 (fr) 2018-01-04
KR20190022762A (ko) 2019-03-06

Similar Documents

Publication Publication Date Title
EP0123901B1 (fr) Procédé pour lier irréversiblement des protéines sur des surfaces de polystyrène avec conservation de leur activité biologique, surfaces de polystyrène obtenues par ce procédé et leur utilisation
US9506913B2 (en) Method of detecting surrogate markers in a serum sample
JP3809177B2 (ja) アフィニティー粒子及びアフィニティー分離方法
JP6733079B2 (ja) 試料中の抗糖脂質抗体の測定試薬及び測定方法
CN114324279B (zh) 伏马毒素b1的检测方法及生物传感器、试剂盒的制备方法及其应用
KR102208218B1 (ko) 변형된 카디오리핀으로 코팅된 마그네틱 나노비드 및 그 제조 방법
CN106198957B (zh) 改性心磷脂包被的纳米磁珠及其制备方法
KR20110115681A (ko) 페이퍼 크로마토그래피 및 화학발광법을 이용한 마이크로시스틴 검출방법 및 검출키트
JP3922648B2 (ja) アフィニティー粒子及びアフィニティー分離方法
JP2013205159A (ja) 親水性ポリマー層を有する物質固定化用担体
CN105264377A (zh) 可降解的阳离子型表面活性剂及其在增强化学发光中的用途
WO2012066003A1 (fr) Composé pour la liaison covalente de la sonde chimiluminescente n-(4-aminobutyl)-n-éthylisoluminol (abei) à des molécules cibles et ses utilisations
EP3640642B1 (fr) Nouveaux bioconjugués artificiels de la protéine de phospholipide pour la reconnaissance biomoléculaire
CN103159778B (zh) 一种半抗原、其抗原、其相应的抗体及其在检测蒿甲醚中的应用
US11619629B2 (en) Modified cardiolipin-coated magnetic nanobeads and preparation methods therefor
CN106198956A (zh) 改性心磷脂包被的纳米磁珠及其制备方法
WO2018000381A2 (fr) Nanobilles revêtues de cardiolipine modifiées et leur procédé de préparation
JP5062410B2 (ja) 非特異吸着防止剤ならびにプローブ結合粒子およびそれらの製造方法
CN114195821B (zh) 一种心磷脂衍生物及其制备方法和应用
CN106124783B (zh) 改性心磷脂包被的纳米磁珠及其制备方法
CN118240220A (zh) 聚醚胺化合物及其制备方法和封闭剂
RU2253871C1 (ru) Способ получения иммуносорбента
KR100460177B1 (ko) 탄수화물칩 제작방법
CN116589558A (zh) 一种固载在bsa蛋白上的改性磷脂及其制备方法与应用
JP4246012B2 (ja) リガンドを担持した担体の製造方法および前記担体を用いて免疫学的測定を行う方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190125

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190128

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200615

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20201204

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210121

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210121

End annual number: 3

Start annual number: 1

PG1601 Publication of registration